Is Ozempic Approved for Weight Loss? The Short Answer
Ozempic is FDA-approved for type 2 diabetes, not weight loss. Why it still causes weight loss, how Wegovy differs, and what off-label use means for cost.
Written by Dr. Sheri Tomas. Updated October 23, 2026.
No. Ozempic is not FDA-approved for weight loss. It is approved for adults with type 2 diabetes, to lower blood sugar and to cut the risk of heart attack, stroke and kidney disease getting worse. The same medicine, semaglutide, is approved for weight loss under a different brand name: Wegovy.
So why do so many people lose weight on Ozempic, and why do some doctors prescribe it anyway? Here is the short answer, the fine print, and what it means for your prescription, your insurance and your wallet.
Is Ozempic Approved for Weight Loss? The Short Answer
- 1Ozempic (semaglutide injection) is FDA-approved only for adults with type 2 diabetes.
- 2Ozempic tablets, approved in February 2026 as the new name for oral semaglutide, are also for type 2 diabetes only.
- 3Weight loss is a well-known effect of Ozempic, but it is not an approved use on its own.
- 4Wegovy is the semaglutide brand approved for chronic weight management, at higher doses than Ozempic.
- 5A doctor can still prescribe Ozempic "off-label" for weight loss, but insurance rarely pays for that.
What Ozempic Is Approved For
According to its FDA label, Ozempic injection is approved for adults with type 2 diabetes to:
- 1Improve blood sugar control, together with diet and exercise
- 2Lower the risk of major heart problems, such as heart attack, stroke or death from heart disease, in people who also have heart disease
- 3Reduce the risk of kidney disease getting worse, kidney failure and death from heart disease in people who also have chronic kidney disease
Nothing on that list is weight loss. If you want the full picture of what Ozempic does for blood sugar, see our guide to Ozempic for type 2 diabetes.
Why Ozempic Causes Weight Loss Anyway
Semaglutide copies a gut hormone called GLP-1. It tells your brain you are full, slows down how fast your stomach empties, and quiets food cravings. People eat less without trying as hard, and the weight comes off. That is true whether or not you have diabetes.
In studies of people with type 2 diabetes, the effect is real but more modest than many headlines suggest. In the SUSTAIN FORTE trial, people on the highest Ozempic dose, 2 mg, lost about 6.9 kg (around 15 pounds) on average over 40 weeks. In the STEP 2 trial, adults with diabetes and excess weight lost about 7% of their body weight on 1 mg of semaglutide, compared with about 9.6% on the Wegovy dose of 2.4 mg. We explain the mechanism in more depth in how Ozempic helps you lose weight.
Ozempic vs Wegovy: Same Drug, Different Approval
Ozempic and Wegovy contain the same active ingredient and are made by the same company, Novo Nordisk. The difference is what each was tested and approved for, and the dose.
Ozempic and Wegovy compared
Approved for
Type 2 diabetes (blood sugar, heart and kidney protection)
Chronic weight management; heart risk reduction; liver disease (MASH)
Who can use it
Adults with type 2 diabetes
Adults and children 12+ with obesity, or adults with overweight and a weight-related condition
Highest weekly injection dose
2 mg
2.4 mg, or 7.2 mg as Wegovy HD (approved March 2026)
Pill version
Ozempic tablets (type 2 diabetes)
Wegovy pill (weight management)
Average weight loss in key trials
About 7% (diabetes trials)
About 15% at 2.4 mg in people without diabetes; about 21% at 7.2 mg
The bigger results with Wegovy come from two things: a higher dose, and trials in people without diabetes, who tend to lose more weight on GLP-1 drugs. For a full side-by-side, read Ozempic vs Wegovy.
Can a Doctor Prescribe Ozempic for Weight Loss?
Yes. In the United States, doctors are allowed to prescribe an approved drug for a use that is not on its label. This is called off-label prescribing, and it is legal and common. Some doctors choose Ozempic for weight loss because a patient already has supplies, because of availability, or because a patient has prediabetes.
But off-label use comes with practical catches:
- 1Insurance plans usually cover Ozempic only for type 2 diabetes and often require proof, such as an A1C result, before approving it.
- 2Ozempic's top dose (2 mg) is lower than Wegovy's, so weight loss is usually smaller.
- 3If you are prescribed Ozempic only for weight loss, you are typically paying cash.
If weight loss is your main goal and you do not have diabetes, the approved option, Wegovy, is usually the more straightforward route, especially for insurance. Our guide to whether insurance covers Ozempic explains the coverage rules.
What About Compounded Semaglutide?
During the semaglutide shortage, compounding pharmacies were allowed to make copies. FDA declared the shortage over in February 2025, and that permission ended. Compounded semaglutide is not Ozempic, has not been reviewed by FDA for safety or effectiveness, and FDA has warned about dosing errors and poor-quality products. See compounded semaglutide vs Ozempic for the details.
Is It Safe to Use Ozempic for Weight Loss?
The safety profile does not change because of why it was prescribed. The most common side effects are nausea, vomiting, diarrhea and constipation, especially when starting or increasing the dose. Rare but serious risks include pancreatitis, gallbladder problems and, in animal studies, thyroid C-cell tumors. Ozempic is not for people with a personal or family history of medullary thyroid cancer or MEN 2. Read is Ozempic safe before starting.
Ozempic and Wegovy should never be used together, because both contain semaglutide.
If you have type 2 diabetes and want to start, the practical steps are in how to get prescribed Ozempic.
The Bottom Line
Ozempic is not approved for weight loss, even though it often causes it. It is approved for type 2 diabetes. If you want semaglutide for weight management, Wegovy is the version approved for that purpose, at higher doses and with more insurance pathways. If your doctor suggests Ozempic for weight loss anyway, ask about cost, coverage and why it is a better fit than Wegovy for you.
FAQ
No. Ozempic is FDA-approved only for adults with type 2 diabetes. Wegovy, which contains the same drug, is the semaglutide brand approved for weight management.
No. There is no approved use of Ozempic for people without type 2 diabetes. Doctors can prescribe it off-label, but insurance rarely covers it for that.
Novo Nordisk ran separate trials of semaglutide at higher doses for weight management and applied for approval under the Wegovy name. Ozempic was studied and approved for diabetes.
There is no sign of that. Novo Nordisk markets Wegovy, including Wegovy HD and the Wegovy pill, for weight management, so an extra weight-loss approval for Ozempic is unlikely.
In trials of people with type 2 diabetes, average weight loss was roughly 5% to 7% of body weight, depending on dose. Results vary widely from person to person.
Sources
- 1Ozempic (semaglutide) injection prescribing information, Novo Nordisk
- 2Wegovy (semaglutide) injection prescribing information, Novo Nordisk
- 3FDA Approves Ozempic Tablets, Novo Nordisk, February 2026
- 4Efficacy and safety of once-weekly semaglutide 2.0 mg versus 1.0 mg in type 2 diabetes (SUSTAIN FORTE), Lancet Diabetes Endocrinol, 2021
- 5Semaglutide 2.4 mg in adults with overweight or obesity and type 2 diabetes (STEP 2), Lancet, 2021
- 6Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1), NEJM, 2021
- 7FDA approves high-dose Wegovy 7.2 mg for adults with obesity, Healio, March 2026
This article is for general information and is not medical advice. Talk to your doctor about which treatment is right for you.
Dr. Sheri Tomas
Author
Comments (0)
Be the first to comment on this article.
More articles
